MATERIAL SAFETY DATA SHEET - Pfizer

1 Page 1 of 8 Revision date: 15-Dec-2006 MATERIAL SAFETY data SHEET Version: IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING MATERIAL Name: Sertraline Hydrochloride Oral Concentrate - 20 mg/mL Trade Name: ZOLOFT(R) Chemical Family: Mixture Intended Use: Pharmaceutical product used as antidepressant 2. COMPOSITION/INFORMATION ON INGREDIENTS HazardousIngredientCAS NumberEU EINECS List%Sertraline hydrochloride79559-97-0 Not hydroxytoluene, NF128-37-0204-881-4 *Ethyl alcohol (ethanol) , USP56-81-5200-289-5* IngredientCAS NumberEU EINECS List%Menthol, USP89-78-1201-939-0* Additional Information:* Proprietary Ingredient(s) indicated as hazardous have been assessed under standards for workplace SAFETY .

2 3. HAZARDS IDENTIFICATION Appearance:Clear, colorless liquidSignal Word:WARNING Statement of Hazard:Flammable liquid and vapor. May be harmful if swallowed. May cause eye irritation May cause liver effects May cause nervous system effects Dangerous for the environmentAdditional Hazard Information: Short Term: May be harmful if swallowed. May cause irritation (based on components) . Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on : telephone number: ChemSafe (24 hours): +44 (0)208 762 8322 Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Pfizer Ltd Ramsgate Road Sandwich, Kent CT13 9NJ United Kingdom +00 44 (0)1304 616161 Emergency telephone number:CHEMTREC (24 hours): 1-800-424-9300 MATERIAL SAFETY data SHEET _____ MATERIAL Name: Sertraline Hydrochloride Oral Concentrate - 20 mg/mLRevision date: 15-Dec-2006 Page 2 of 8 Version: Clinical Effects.

3 Ingestion of this MATERIAL may cause effects similar to those seen in clinical use including nausea, diarrhea, insomnia, and headache. Signs and symptoms associated with non-fatal overdosage were drowsiness, vomiting, rapid heart rate, nausea, dizziness, agitation, and tremor. EU Risk Phrases: R10 - Flammable. R52 - Harmful to aquatic organisms. Note: This document has been prepared in accordance with standards for workplace SAFETY , which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

4 4. FIRST AID MEASURES Eye Contact:Flush with water while holding eyelids open for at least 15 minutes. Seek medical attention immediately. Skin Contact:Remove contaminated clothing. Flush area with large amounts of water. Use soap. Seek medical attention. Ingestion:Never give anything by mouth to an unconscious person. Wash out mouth with water. Do not induce vomiting unless directed by medical personnel. Seek medical attention immediately. Inhalation:Remove to fresh air and keep patient at rest. Seek medical attention immediately. 5. FIRE FIGHTING MEASURES Extinguishing Media: Use carbon dioxide, dry chemical, or water spray. Hazardous Combustion Products: May emit toxic fumes of carbon monoxide, carbon dioxide, nitrogen oxides, hydrogen chloride and other chlorine-containing compounds.

5 Fire Fighting Procedures: Wear approved positive pressure, self-contained breathing apparatus and full protective turn out gear. Use caution in approaching fire. Fire / Explosion Hazards: Flammable liquid. 6. ACCIDENTAL RELEASE MEASURES Health and SAFETY Precautions: Personnel involved in clean-up should wear appropriate personal protective equipment (see Section 8). Minimize exposure. Eliminate all sources of ignition and ventilate area using explosion-proof equipment. Measures for Cleaning / Collecting: Contain the source of spill if it is safe to do so. Collect spill with absorbent MATERIAL . Clean spill area thoroughly. Measures for Environmental Protections: Place waste in an appropriately labeled, sealed container for disposal.

6 Care should be taken to avoid environmental release. MATERIAL SAFETY data SHEET _____ MATERIAL Name: Sertraline Hydrochloride Oral Concentrate - 20 mg/mLRevision date: 15-Dec-2006 Page 3 of 8 Version: Additional Consideration for Large Spills: Non-essential personnel should be evacuated from affected area. Report emergency situations immediately. Clean up operations should only be undertaken by trained personnel. 7. HANDLING AND STORAGE General Handling: Keep away from heat. Use adequate ventilation. Eliminate possible ignition sources ( , heat, sparks, flame, impact, friction, electricity), and follow appropriate grounding and bonding procedures. Storage Conditions: Keep container tightly closed when not in use.

7 Store out of direct sunlight in a cool, well ventilated, dry area. Storage Temperature:Store as directed by product packaging. 8. EXPOSURE CONTROLS / PERSONAL PROTECTION The exposure limit(s) listed for solid components are only relevant if dust or mist may be generated. Analytical Method: Analytical method available for Sertraline. Contact Pfizer Inc for further information. Engineering Controls: Engineering controls should be used as the primary means to control exposures. Local and general ventilation should be used as necessary, when handling this MATERIAL in bulk. Personal Protective Equipment: Hands:Wear impervious gloves if skin contact is possible. Eyes: SAFETY glasses or goggles Skin:None required with normal use of this MATERIAL .

8 Wear protective clothing with long sleeves when working with large quantities. Wash hands and arms thoroughly after handling this MATERIAL . Clean up spills immediately. Respiratory protection:If the applicable Occupational Exposure Limit (OEL) is exceeded, wear an appropriate respirator with a protection factor sufficient to control exposures to below the OEL. ACGIH Threshold Limit Value (TWA)= 10 mg/m3 TWAS ertraline hydrochloride Australia TWA = 10 mg/m3 TWA Australia TWA = 10 mg/m3 TWA Ethyl alcohol (ethanol) Pfizer OEL TWA-8 Hr: mg/m OSHA - Final PELS - TWAs:= 1000 ppm TWA = 1900 mg/m3 TWA ACGIH Threshold Limit Value (TWA)= 1000 ppm TWAB utylated hydroxytoluene, NF Australia TWA = 1000 ppm TWA = 1880 mg/m3 TWAG lycerin, USP OSHA - Final PELS - TWAs:= 15 mg/m3 TWA total = 5 mg/m3 TWAACGIH Threshold Limit Value (TWA)= 2 mg/m3 TWA MATERIAL SAFETY data SHEET _____ MATERIAL Name.

9 Sertraline Hydrochloride Oral Concentrate - 20 mg/mLRevision date: 15-Dec-2006 Page 4 of 8 Version: PHYSICAL AND CHEMICAL PROPERTIES: Partition Coefficient (Calculated; pH - Log D): at pH 7 Flash Point (Liquid) ( C):27 Partition Coefficient (n-octanol/water - Log P): (pH 7) (Sertraline HCl) 10. STABILITY AND REACTIVITY Stability:Stable under normal conditions of use. Conditions to Avoid:Direct sunlight, excessive heat, sparks or open flame Incompatible Materials:As a precautionary measure, keep away from strong oxidizers. 11. TOXICOLOGICAL INFORMATION General Information:The information included in this section describes the potential hazards of the individual ingredients.

10 Acute Toxicity: (Species, Route, End Point, Dose)Acute Toxicity Comments: A greater than symbol (>) indicates that the toxicity endpoint being tested was not achievable at the highest dose used in the / Sensitization: (Study Type, Species, Severity) Rat Dermal LD 50 > g/kgSertraline hydrochlorideEthyl alcohol (ethanol)Molecular Formula: MixtureMouse Oral LD50 3450 mg/kgMouse Oral LD50 419 - 548 mg/kgRat Oral LD50 7060 mg/kgRat Inhalation LC50 10h 20,000 ppmRat Oral LD50 1327 - 1591 mg/kgButylated hydroxytoluene, NFMolecular Weight:MixtureRat Oral LD50 890 mg/kgGlycerin, USPM ouse Oral LD50 4090 mg/kgGlycerin, USPP hysical State: LiquidEye Irritation Rabbit MildRat Oral LD50 g/kgEthyl alcohol (ethanol)Eye Irritation Rabbit SevereRabbit Dermal LD50 > 10 g/kgColor:Clear, colorless Rat Inhalation LC50 1hr > 570 mg/m3 MATERIAL SAFETY data SHEET _____ MATERIAL Name: Sertraline Hydrochloride Oral Concentrate - 20 mg/mLRevision date: 15-Dec-2006 Page 5 of 8 Version: Dose Toxicity: (Duration, Species, Route, Dose, End Point, Target Organ)Reproduction & Developmental Toxicity.